Thermo Fisher continues its expansion drive with opening of $160M Massachusetts facility
Thermo Fisher is looking much closer to home for its latest opening.
On Tuesday, the manufacturer opened a new $160 million, 85,000 square-foot facility in Chelmsford, MA, 30 miles north of its headquarters in Waltham. According to a Thermo Fisher spokesperson, the company broke ground on the site in 2020.
The Chelmsford site also is part of a wider $650 million investment that Thermo Fisher has made in new sites across the US, UK, Singapore and China.
The site will produce resins that are used in medicines and biologics as well as cell and gene therapies, according to a spokesperson. The spokesperson also confirmed that production has already begun.
The facility also will be able to hold around 250 employees when fully staffed and currently employs 140.
“The Chelmsford site will help us provide our customers with the critical resin materials they need as they scale up production and bring new innovations to market. This ultimately helps ensure more patients get the treatments they need faster,” said Jean Luo, VP and general manager for purification and pharma analytics at Thermo Fisher, in a statement.
Thermo Fisher is investing heavily in the Bay State, as it opened a $180 million, 300,000-square- foot viral vector manufacturing site in Plainview, about 48 miles from Boston, only a few weeks ago.
As part of this $650 million investment, the company has been steadily opening sites across the nation throughout the year too.
In April, the company opened a $44 million site in Utah that manufactures bioprocess container systems.
Last month, the company really picked up the pace as it opened new facilities, including a $76 million cell culture manufacturing site opened outside of Buffalo, NY, and a $105 million biologics site in Lebanon, TN, just outside of Nashville.
